Argos Therapeutics, Inc. – NASDAQ:ARGS

Argos Therapeutics stock price today

0.28
+0.00
+3.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

Argos Therapeutics stock price monthly change

-75.23%
month

Argos Therapeutics stock price quarterly change

-88.84%
quarter

Argos Therapeutics stock price yearly change

-97.22%
year

Argos Therapeutics key metrics

Market Cap
2.13M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1611.59
Revenue
8.90M
EBITDA
-15.48B
Income
-15.48B
Revenue Q/Q
2231.44%
Revenue Y/Y
2171.26%
Profit margin
-173866.79%
Oper. margin
-173866.79%
Gross margin
100%
EBIT margin
-173866.79%
EBITDA margin
-173837.85%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Argos Therapeutics stock price history

Argos Therapeutics stock forecast

Argos Therapeutics financial statements

Argos Therapeutics, Inc. (NASDAQ:ARGS): Profit margin
Dec 2017 1.67M -1.89B -113281.31%
Mar 2018 5.93M -2.11B -35585.59%
Jun 2018 54.24K -6.47B -11942992.24%
Sep 2018 1.24M -5.00B -400932.53%
Argos Therapeutics, Inc. (NASDAQ:ARGS): Debt to assets
Dec 2017 20777764 30.01M 144.44%
Mar 2018 22164168 25.34M 114.34%
Jun 2018 16788124 24.92M 148.46%
Sep 2018 10880900 23.45M 215.55%
Argos Therapeutics, Inc. (NASDAQ:ARGS): Cash Flow
Dec 2017 -3.91M 2.52M 7.19M
Mar 2018 -5.45M 305.58K 6.97M
Jun 2018 -5.32M 304.3K 131.39K
Sep 2018 -3.86M 20.32K -339.70K

Argos Therapeutics other data

Argos Therapeutics, Inc. (NASDAQ:ARGS): Insider trades (number of shares)
Period Buy Sel
Jan 2018 0 1155005
Transaction Date Insider Security Shares Price per share Total value Source
Sale
HARRELSON LORI R. officer: Vice President of Fina..
Common Stock 64,329 $0.17 $10,614
Sale
KATZ RICHARD D officer: Vice President and CFO
Common Stock 104,435 $0.17 $17,232
Sale
NICOLETTE CHARLES A. officer: CSO and Vice President..
Common Stock 100,250 $0.17 $16,541
Sale
ABBEY JEFFREY D director, officer: Chief Execut..
Common Stock 124,987 $0.17 $20,623
Sale
HARRELSON LORI R. officer: Vice President of Fina..
Common Stock 64,329 $0.17 $10,614
Sale
KATZ RICHARD D officer: Vice President and CFO
Common Stock 104,435 $0.17 $17,232
Sale
NICOLETTE CHARLES A. officer: CSO and Vice President..
Common Stock 100,250 $0.17 $16,541
Sale
ABBEY JEFFREY D director, officer: Chief Execut..
Common Stock 124,987 $0.17 $20,623
Sale
HARRELSON LORI R. officer: Vice President of Fina..
Common Stock 59,072 $0.16 $9,688
Sale
KATZ RICHARD D officer: Vice President and CFO
Common Stock 101,228 $0.16 $16,500
Patent
Application
Filling date: 3 Nov 2017 Issue date: 17 Oct 2019
  • What's the price of Argos Therapeutics stock today?

    One share of Argos Therapeutics stock can currently be purchased for approximately $0.28.

  • When is Argos Therapeutics's next earnings date?

    Unfortunately, Argos Therapeutics's (ARGS) next earnings date is currently unknown.

  • Does Argos Therapeutics pay dividends?

    No, Argos Therapeutics does not pay dividends.

  • How much money does Argos Therapeutics make?

    Argos Therapeutics has a market capitalization of 2.13M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 100.9% to 1.9M US dollars.

  • What is Argos Therapeutics's stock symbol?

    Argos Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "ARGS".

  • What is Argos Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Argos Therapeutics?

    Shares of Argos Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • What is Argos Therapeutics's official website?

    The official website for Argos Therapeutics is argostherapeutics.com.

Argos Therapeutics company profile:

Argos Therapeutics, Inc.

argostherapeutics.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare


,

CIK: 0001105533
:
: